Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate


CAS No. : 632-93-9

632-93-9
Price and Availability of CAS No. : 632-93-9
Size Price Stock
5g $7 In-stock
25g $32 In-stock
100g $111 In-stock
200 g Get quote
500 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-118594
M.Wt: 267.32
Formula: C14H21NO4
Purity: >98 %
Solubility: DMSO : 100 mg/mL (ultrasonic)
Introduction of 632-93-9 :

Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate is an orally active porphyrin inducer and ferrochelatase inhibitor. Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate can induce small bile duct obstruction in mice, resulting in blocked bile excretion and causing cholestasis. Long-term use of Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate can cause damage to bile duct epithelial cells, inflammatory responses, and liver fibrosis. Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate can be used to simulate the pathological features of cholestatic liver diseases such as sclerosing cholangitis (PSC)[1][2][3][4][5][6]. In Vivo:Note:
Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.

Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate (0.17%; fed; continuously for 10 weeks) in 1-month-old male C3H mice induces the formation of Mallory Denk bodies (MDB). Refeeding Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate after drug withdrawal increases the proportion of FAT10-positive hepatocytes. Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate also alters the expression of tumor-related genes, and liver tumors form in mice after long-term drug withdrawal[1].
Diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate (20 mg/100 g body weight; intraperitoneal injection; once, 4 h before Phenobarbital, Phorone, or Hemin (HY-19424) administration) blocks heme synthesis, prevents the induction of HO-1 by oxidative stress, and inhibits the increase in serum iron induced by phenobarbital in C57BL/6 mice with selenium deficiency or sufficiency[2].

Inducing Cholestatic Liver Injury[3][4][5][6]
Background
Diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate is a porphyrin precursor that inhibits the mitochondrial enzyme ferrochelatase. This enzyme is responsible for inserting ferrous ions into protoporphyrin IX to form heme. Its inhibition leads to the accumulation of protoporphyrin in hepatocytes and Kupffer cells. Due to its hydrophobic nature, protoporphyrin can only be excreted through bile. Excess protoporphyrin precipitates in the bile canaliculi and bile ducts, forming crystals that block and damage the bile duct system.
Specific Modeling Methods
Mice: C57BL6/J mice • male • 8-12 week-old
Administration: 0.1% (wt/wt) evenly mixed into standard rat diet • Free access • for 8, 14, 17 or 28 days (depending on the degree of injury)
or Caerulein (50 μg/kg, 7 hourly, total 7 times) plus LPS (10 mg/kg, once) • i.p.
Note
(1) Diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate diet was ineffective in rats and did not induce biliary response (DR).
(2) Diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate model is robust, reproducible, and has little impact on animal welfare; different strains of mice can produce similar phenotypes.
(3) The exposure time and whether to use the recovery period for Diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate can be adjusted according to the actual situation.
Modeling Indicators
Molecular changes: Serum bilirubin, P4HA2, α-SMA, CK19/CK7/SOX9 levels were significantly elevated, while alanine aminotransferase (ALT) levels were slightly elevated.
Histology analysis: The liver turned dark brown (indicating protoporphyrin pigment accumulation), and H&E staining showed that the damage was mainly concentrated in the portal vein area, accompanied by bile duct reaction, inflammation, and fibrosis.

Your information is safe with us.

Our product is for R&D purpose only.